TRIALECO
Discuss a pilot

For investors

A modular platform with a testable path to scale

Trialeco's investment case: entry workflow, buyers, evidence ledger, commercial hypotheses and verifiable milestones—without unsupported metrics.

INVESTMENT THESIS

From one testable workflow to a unified clinical-trial operating layer.

Trialeco does not begin by replacing the entire stack. It starts with a bounded workflow and measurable criteria, expands to a module package, then connects the system through Trialeco Core.

Investment logic

01

One module

A bounded task, permitted data, accountable roles and acceptance criteria.

02

Workflow package

Connected modules exchange events and preserve one project action log.

03

Ecosystem

Planned project-specific integrations after compatibility, legal and security review.

Designed for

Sponsors

Requirements, site readiness, recruitment and quality oversight without replacing accountable professionals.

CROs

A routing and observability layer over existing operational systems.

Research sites

Support for prescreening, communications, workload and documented checkpoints.

EVIDENCE

Evidence ledger

Software results, specifications, demonstrations and planned capabilities are labelled separately.

Protocol GuardRequirements documented

Criteria logic is documented in the Recruit specification; the public scenario is synthetic

RecruitSpecification + demo

Detailed specification; local reference and prospective evaluation required

CommsSpecification + video

Specification and explainer; video publication awaits channel and editorial review

Site StatusMetrics + video

Metrics map and explainer; no operational effect is claimed

OrchestratorEvent and state maps

Routing architecture documented; people approve critical transitions

QualityDesigned domain

A project action log, deviation drafts and CAPA support are described; standalone maturity requires clarification

BUSINESS MODEL

Commercial model—hypotheses to test

  • Paid single-workflow pilot
  • Module licence or subscription
  • Integration and support services
  • Expansion after a measured pilot
DEFENSIBILITY

Potential defensibility

  • Unified trial event and state model
  • Labelled workflows and error classes
  • Modular validation method
  • Professional, patient and ethics domains connected

These are testable hypotheses, not claims of proven advantage. A complete investment memo requires confirmed pilots, IP, economics, pipeline, intended use and validation reports.

MILESTONES

Near-term verifiable milestones

  1. 01Define module status and intended use
  2. 02Select the first paid pilot and baseline
  3. 03Build the evidence ledger and validation report
  4. 04Confirm IP, integrations and data architecture
  5. 05Calculate TAM/SAM/SOM and unit economics with a documented method

Request an investor briefing

Do not send patient information or medical documents.

Open the contact form ↗